OrbusNeich Medical Group Holdings Limited
OrbusNeich Medical Group Holdings Limited (HKSE: 6929) is trading at HK$3.80, about ₹47 at today's HKD/INR rate, as of 30 Sep 2026, 1:16 AM ET, up 0.40% today. Indian residents can buy OrbusNeich Medical Group from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$3.79
Today's high
HK$3.84
52 week low
HK$3.45
52 week high
HK$5.10
6929 opened at HK$3.79, closed previously at HK$3.79, and has traded between HK$3.45 and HK$5.10 over the past 52 weeks.
About
OrbusNeich Medical Group Holdings Limited functions as an investment holding entity, specializing in the development, distribution, sales, and marketing of medical instruments tailored for treating coronary and peripheral vascular ailments. The company boasts a significant international presence, serving markets across Japan, Europe, the Middle East, Africa, the Asia Pacific region, the People's Republic of China, and the United States. Its product offerings encompass a range of essential devices, including semi-compliant and scoring balloons used for initial vessel preparation, coronary stents for implantation, non-compliant balloons designed for post-dilatation, and a variety of specialized catheters. This extensive portfolio of products addresses critical steps within percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Founded in 2001, the company is headquartered in Shatin, Hong Kong, and operates as a subsidiary of Harmony Tree Limited.
Key statistics
Avg. volume
172.47K
Market cap
HK$3.13B
P/E Ratio
9.04
Price-to-sales ratio
2.04
Enterprise value
$168.78M
Free cash flow yield
0.30%
Debt-to-equity ratio
0.02
Return on equity
10.15%
ROIC
8.37%
Beta
-0.63
Dividend yield
5.26%
Last dividend
HK$0.27
Financial overview
Revenue
$180.45M
Earnings per share
$0.05
Free cash flow
$1.15M
Net profit margin
22.33%
Gross margin
68.60%
EBITDA
$42.78M
Revenue growth
9.97%
Similar securities
This is not an investment recommendation
How to buy OrbusNeich Medical Group from India
Indian residents can buy OrbusNeich Medical Group shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for OrbusNeich Medical Group and place an order
Find OrbusNeich Medical Group by name or by its ticker, 6929, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. OrbusNeich Medical Group trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your OrbusNeich Medical Group position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in OrbusNeich Medical Group from India
Trading and taxes when buying OrbusNeich Medical Group from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. OrbusNeich Medical Group’s current yield is 5.26%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy OrbusNeich Medical Group stock?
Yes. OrbusNeich Medical Group (6929) has been listed on the Hong Kong Stock Exchange since 2022, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one OrbusNeich Medical Group share cost in rupees?
One OrbusNeich Medical Group share is HK$3.80 — about ₹47 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the OrbusNeich Medical Group price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying OrbusNeich Medical Group from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of OrbusNeich Medical Group?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on OrbusNeich Medical Group shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the OrbusNeich Medical Group price. Paasa issues a capital-gains statement for your return.
Does OrbusNeich Medical Group pay a dividend, and how is it taxed in India?
Yes. OrbusNeich Medical Group pays a dividend and the current yield is 5.26%; the last declared dividend was HK$0.27 per share, about ₹3.30. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade OrbusNeich Medical Group from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on OrbusNeich Medical Group shares held from India?
Hong Kong has no estate duty.
Do I have to declare OrbusNeich Medical Group shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your OrbusNeich Medical Group holding, its cost and its closing value.
How do I sell OrbusNeich Medical Group and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.